Dr Jennifer Spillane joins Professor Nils Erik Gilhus to discuss how recently launched medications targeting the pathogenic mechanisms of MG will impact management of the condition and the lives of patients.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
